SK9782000A3 - Macrolides, method for production thereof and pharmaceutical compositions on their base - Google Patents

Macrolides, method for production thereof and pharmaceutical compositions on their base Download PDF

Info

Publication number
SK9782000A3
SK9782000A3 SK978-2000A SK9782000A SK9782000A3 SK 9782000 A3 SK9782000 A3 SK 9782000A3 SK 9782000 A SK9782000 A SK 9782000A SK 9782000 A3 SK9782000 A3 SK 9782000A3
Authority
SK
Slovakia
Prior art keywords
alkyl
hydroxy
carbon atoms
hydrogen
optionally substituted
Prior art date
Application number
SK978-2000A
Other languages
English (en)
Slovak (sk)
Inventor
John Philip Dirlam
Hamish Alastair Irvin Mcarthur
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of SK9782000A3 publication Critical patent/SK9782000A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
SK978-2000A 1998-01-02 1998-12-21 Macrolides, method for production thereof and pharmaceutical compositions on their base SK9782000A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7034398P 1998-01-02 1998-01-02
PCT/IB1998/002099 WO1999035156A1 (en) 1998-01-02 1998-12-21 Novel macrolides

Publications (1)

Publication Number Publication Date
SK9782000A3 true SK9782000A3 (en) 2001-12-03

Family

ID=22094723

Family Applications (1)

Application Number Title Priority Date Filing Date
SK978-2000A SK9782000A3 (en) 1998-01-02 1998-12-21 Macrolides, method for production thereof and pharmaceutical compositions on their base

Country Status (34)

Country Link
US (2) US6472371B1 (cs)
EP (1) EP1044207A1 (cs)
JP (1) JP2002500230A (cs)
KR (1) KR100352809B1 (cs)
CN (1) CN1284081A (cs)
AP (1) AP9801420A0 (cs)
AR (4) AR014948A1 (cs)
AU (1) AU756409B2 (cs)
BG (1) BG104644A (cs)
BR (1) BR9814601A (cs)
CA (1) CA2316919C (cs)
CO (1) CO4970821A1 (cs)
CZ (1) CZ20002458A3 (cs)
DZ (1) DZ2698A1 (cs)
EA (1) EA200000594A1 (cs)
GT (1) GT199800206A (cs)
HR (1) HRP20000442A2 (cs)
HU (1) HUP0100420A3 (cs)
IL (1) IL137024A0 (cs)
IS (1) IS5528A (cs)
MA (1) MA24729A1 (cs)
NO (1) NO20003347L (cs)
NZ (1) NZ504986A (cs)
OA (1) OA11438A (cs)
PA (1) PA8465301A1 (cs)
PE (1) PE20000049A1 (cs)
PL (1) PL341642A1 (cs)
SK (1) SK9782000A3 (cs)
TN (1) TNSN98238A1 (cs)
TW (1) TW520374B (cs)
UY (2) UY25330A1 (cs)
WO (1) WO1999035156A1 (cs)
YU (1) YU41500A (cs)
ZA (1) ZA9811939B (cs)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP1060A (en) 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
AP9801420A0 (en) 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
US6043227A (en) * 1998-08-19 2000-03-28 Pfizer Inc. C11 carbamates of macrolide antibacterials
EP1437360A3 (en) * 1998-08-19 2005-04-06 Pfizer Products Inc. C11 Carbamates of macrolide antibacterials
EP1754700A3 (en) 1999-01-27 2007-05-09 Kosan Biosciences, Inc. Synthesis of oligoketides
US6399582B1 (en) 1999-04-16 2002-06-04 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
US6590083B1 (en) 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
US6451768B1 (en) 1999-04-16 2002-09-17 Kosan Biosciences, Inc. Macrolide antiinfective agents
AU3832100A (en) 1999-05-24 2000-12-12 Pfizer Products Inc. 13-methyl-erythromycin derivatives
JPWO2003072589A1 (ja) * 2002-02-26 2005-06-16 明治製菓株式会社 新規１５員環アザライド及び新規１６員環ジアザライド誘導体とその製造法
AU2005286723A1 (en) 2004-09-23 2006-03-30 Schering-Plough Pty. Limited Control of parasites in animals by the use of novel trifluoromethanesulfonanilide oxime ether derivatives
ATE446677T1 (de) * 2004-11-19 2009-11-15 Schering Plough Ltd Kontrolle von parasiten bei tieren mittels verwendung von parasitiziden 2-phenyl-3-(1h- pyrrol-2-yl) acrylonitril-derivaten
CA2591746A1 (en) 2004-12-21 2006-06-29 Pfizer Products Inc. Macrolides
MX2007015729A (es) * 2005-06-09 2008-02-21 Schering Plough Ltd Control de parasitos en animales con derivados de n-[(feniloxi)fenil]-1,1,1-trifluorometansulfonamida y de n[(fenilsulfanil)fenil]-1,1,1-trifluorometansulfonamida.
US8119667B2 (en) * 2005-12-29 2012-02-21 Schering-Plough Animal Health Corporation Carbonates of fenicol antibiotics
US20070238700A1 (en) * 2006-04-10 2007-10-11 Winzenberg Kevin N N-phenyl-1,1,1-trifluoromethanesulfonamide hydrazone derivative compounds and their usage in controlling parasites
WO2008076256A1 (en) * 2006-12-13 2008-06-26 Schering-Plough Ltd. Water-soluble prodrugs of chloramphenicol, thiamphenicol, and analogs thereof
WO2008076259A1 (en) * 2006-12-13 2008-06-26 Schering-Plough Ltd. Water-soluble prodrugs of florfenicol and its analogs
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
NO2957284T3 (cs) 2007-06-27 2018-06-16
US20090131343A1 (en) * 2007-11-15 2009-05-21 Ly Tam Phan Use of bridged macrolides or tylosin derivatives in treating inflammatory bowel diseases
TWI401023B (zh) 2008-02-06 2013-07-11 Du Pont 中離子農藥
JP2011529895A (ja) * 2008-07-30 2011-12-15 インターベツト・インターナシヨナル・ベー・ベー フロルフェニコール中間体として有用なオキサゾリン保護アミノジオール化合物を調製する方法
IN2012DN00838A (cs) 2009-08-05 2015-06-26 Du Pont
UA107804C2 (en) 2009-08-05 2015-02-25 Du Pont Mixtures of pesticides mezoionnyh
JP2013501059A (ja) 2009-08-05 2013-01-10 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー メソイオン性殺虫剤
UA110924C2 (uk) 2009-08-05 2016-03-10 Е. І. Дю Пон Де Немур Енд Компані Мезоіонні пестициди
EP2576523B1 (en) 2010-05-27 2016-01-13 E. I. du Pont de Nemours and Company Crystalline form of 4-[5 - [3 -chloro-5 -(trifluoromethyl)phenyl] -4,5 -dihydro-5 -(trifluoromethyl)-3 - isoxazolyl]-n-[2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl]-1- naphthalenecarboxamide
WO2012087630A1 (en) 2010-12-20 2012-06-28 E.I. Du Pont De Nemours And Company Pyridine and pyrimidine compounds for controlling invertebrate
CN103380141A (zh) * 2011-01-31 2013-10-30 明治制果药业株式会社 新大环内酯衍生物
MX2013014326A (es) 2011-06-20 2014-01-23 Du Pont Compuestos heterociclicos para tratar infecciones por helmintos.
CN102260306B (zh) * 2011-07-22 2012-07-18 山东鲁抗舍里乐药业有限公司 一种制备泰拉霉素的方法
US20140315857A1 (en) 2011-11-28 2014-10-23 E I Du Pont De Nemours And Company N- (4 -quinolinylmethyl) sulfonamide derivatives and their use as anthelmintics
WO2013158422A1 (en) 2012-04-17 2013-10-24 E. I. Du Pont De Nemours And Company Heterocyclic compounds for controlling invertebrate pests
WO2014099837A1 (en) 2012-12-18 2014-06-26 E. I. Du Pont De Nemours And Company Sulfonamide anthelmintics
CN105669798B (zh) * 2013-08-23 2019-07-26 普莱柯生物工程股份有限公司 一种大环内酯类化合物
CN103965273B (zh) * 2013-08-23 2016-05-25 普莱柯生物工程股份有限公司 一种大环内酯类化合物

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3652537A (en) 1969-11-21 1972-03-28 Lilly Co Eli Epierythromycylamine and epierythromycyl b amine
US3923784A (en) 1973-09-10 1975-12-02 Hoffmann La Roche Erythromycin a derivatives
YU43116B (en) 1979-04-02 1989-04-30 Pliva Pharm & Chem Works Process for preparing 11-aza-4-o-cladinosyl-6-o-desosaminyl-15-ethyl-7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl-oxacyclopentadecane-2-one(11-aza-10-deox
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
US4585759A (en) 1985-01-22 1986-04-29 Pfizer Inc. Antibacterial derivatives of a neutral macrolide
EP0283055B1 (en) * 1987-09-03 1990-08-29 SOUR PLIVA farmaceutska, Kemijska prehrambena i kozmeticka industrija, n.sol.o. 10-dihydro-10-deoxo-11-azaerythronolide-a-compounds, methods and intermediates for the manufacture thereof and their use in pharmaceuticals and in the manufacture thereof
US5141926A (en) 1990-04-18 1992-08-25 Abbott Laboratories Erythromycin derivatives
US5824513A (en) 1991-01-17 1998-10-20 Abbott Laboratories Recombinant DNA method for producing erythromycin analogs
WO1993013663A1 (en) 1992-01-17 1993-07-22 Abbott Laboratories Method of directing biosynthesis of specific polyketides
US5985844A (en) 1992-03-26 1999-11-16 Merck & Co., Inc. Homoerythromycin A derivatives modified at the 4"-and 8A-positions
CA2065218A1 (en) 1991-04-11 1992-10-12 Robert R. Wilkening Process for the preparation of 9-deoxo-8a-aza-8a-homoerythromycin a and its 8a-alkyl derivatives
US5523399A (en) * 1991-12-27 1996-06-04 Taisho Pharmaceutical Co., Ltd. 5-O-desosaminylerythronolide derivatives
FR2691464B1 (fr) * 1992-05-21 1995-06-02 Roussel Uclaf Nouveaux dérivés de la 1-oxa 6-azacyclopentadécane 13,15-dione, leur procédé de préparation et leur application comme médicaments.
US5332807A (en) * 1993-04-14 1994-07-26 Merck & Co., Inc. Process of producing 8A- and 9A-azalide antibiotics
US5441939A (en) * 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
US6271255B1 (en) 1996-07-05 2001-08-07 Biotica Technology Limited Erythromycins and process for their preparation
AU6932098A (en) 1997-05-09 1998-12-08 Pfizer Products Inc. Erythromycin derivatives
US6407074B1 (en) 1997-06-11 2002-06-18 Pfizer Inc C-4″-substituted macrolide derivatives
US20020025937A1 (en) 2000-03-20 2002-02-28 Yong-Jin Wu 9-oxime erythromycin derivatives
HN1998000074A (es) * 1997-06-11 1999-01-08 Pfizer Prod Inc Derivados de macrolidos c-4 sustituidos
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
AU7961498A (en) 1997-06-26 1999-01-19 Merck & Co., Inc. 9a-azalides, compositions containing such compounds and methods of treatment
US6339063B1 (en) 1997-09-10 2002-01-15 Merck & Co., Inc. 9a-azalides as veterinary antimicrobial agents
HN1998000159A (es) 1997-10-29 1999-02-09 Monsanto Co Derivados de 9- amino - 3 ceto eritromicina
PA8461401A1 (es) 1997-10-29 2000-05-24 Pfizer Prod Inc Derivados de eritromicina triciclicos
AP1060A (en) 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
AP9801420A0 (en) 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
DK0941998T3 (da) 1998-03-03 2004-09-20 Pfizer Prod Inc 3,6-ketalmakrolidantibiotika
AU3439899A (en) 1998-06-03 1999-12-20 Pfizer Products Inc. Tricyclic 3-keto derivatives of 6-o-methylerythromycin
US6043227A (en) 1998-08-19 2000-03-28 Pfizer Inc. C11 carbamates of macrolide antibacterials
US6100240A (en) 1998-10-09 2000-08-08 Pfizer Inc Macrolide derivatives
BR9914998A (pt) 1998-11-03 2001-07-10 Pfizer Prod Inc Antibióticos macrólidos
UA70972C2 (uk) 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків
AU3832100A (en) 1999-05-24 2000-12-12 Pfizer Products Inc. 13-methyl-erythromycin derivatives
EP1101769A3 (en) 1999-11-18 2001-10-24 Pfizer Products Inc. Nitrogen containing erythromycin derivatives
WO2003014136A1 (en) 2001-08-08 2003-02-20 Taisho Pharmaceutical Co., Ltd. 11a-AZALIDE COMPOUNDS AND PROCESS FOR PRODUCING THE SAME

Also Published As

Publication number Publication date
AR020551A2 (es) 2002-05-15
US7015203B2 (en) 2006-03-21
NO20003347D0 (no) 2000-06-27
UY25330A1 (es) 2000-12-29
CA2316919A1 (en) 1999-07-15
UY25574A1 (es) 1999-09-27
WO1999035156A1 (en) 1999-07-15
CA2316919C (en) 2004-10-26
NO20003347L (no) 2000-08-28
US20040092459A1 (en) 2004-05-13
AR019787A2 (es) 2002-03-13
AP9801420A0 (en) 1998-12-31
US6472371B1 (en) 2002-10-29
PA8465301A1 (es) 2000-09-29
EP1044207A1 (en) 2000-10-18
TNSN98238A1 (fr) 2005-03-15
KR20010024818A (ko) 2001-03-26
MA24729A1 (fr) 1999-07-01
EA200000594A1 (ru) 2001-04-23
OA11438A (en) 2004-04-30
DZ2698A1 (fr) 2003-03-29
BR9814601A (pt) 2000-10-17
HUP0100420A3 (en) 2003-07-28
NZ504986A (en) 2003-03-28
AR020851A2 (es) 2002-05-29
ZA9811939B (en) 2000-06-30
CZ20002458A3 (cs) 2001-10-17
PE20000049A1 (es) 2000-02-07
AR014948A1 (es) 2001-04-11
AU1444799A (en) 1999-07-26
HRP20000442A2 (en) 2001-04-30
YU41500A (sh) 2003-02-28
AU756409B2 (en) 2003-01-09
WO1999035156B1 (en) 1999-10-21
GT199800206A (es) 2000-06-21
KR100352809B1 (ko) 2002-11-01
BG104644A (en) 2001-01-31
IL137024A0 (en) 2001-06-14
CO4970821A1 (es) 2000-11-07
HUP0100420A2 (hu) 2001-07-30
JP2002500230A (ja) 2002-01-08
IS5528A (is) 2000-06-09
CN1284081A (zh) 2001-02-14
TW520374B (en) 2003-02-11
PL341642A1 (en) 2001-04-23

Similar Documents

Publication Publication Date Title
US6472371B1 (en) Macrolides
CA2292359C (en) Novel azalides and methods of making same
US6825171B2 (en) Erythromycin derivatives
EP1131331B1 (en) 13-membered azalides and their use as antibiotic agents
CA2293335A1 (en) 9-oxime erythromycin derivatives
EP0984019B1 (en) C11 carbamates of macrolide antibacterials
WO1998051696A1 (en) Erythromycin derivatives
US20020151507A1 (en) 9-oxime erythromycin derivatives
MXPA00006604A (en) Novel macrolides
MXPA00001110A (en) Novel azalides and methods of making same
EP1437360A2 (en) C11 Carbamates of macrolide antibacterials